News PagePear Therapeutics Pear Therapeutics Initiates Feasibility Study to Treat Depressive Symptoms In People With Multiple Sclerosis Pear Therapeutics, Inc. recently announced the start of a feasibility study for a prescription digital…Arboretum_JDMay 8, 2019
Home PageNews PageStrata Oncology Arcus Biosciences and Strata Oncology Announce Clinical Development Collaboration for Anti-PD-1 Antibody AB122 Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, and…Arboretum_JDMay 2, 2019
Cardiac DimensionsHome PageNews Page New Data Confirms Cardiac Dimensions’ Carillon® System Provides Acute Hemodynamic Efficacy in Patients with Functional Mitral Regurgitation Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments to address functional…Arboretum_JDApril 26, 2019
News PageSI-Bone SI-BONE, Inc. Announces FDA Clearance of iFuse Bedrock™ Novel Spinopelvic Fixation Technology SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley based medical device company dedicated to solving musculoskeletal…Arboretum_JDApril 15, 2019
Advanced ICU CareNews Page Advanced ICU Care Announces Continued Tele-ICU Success with 2018 Performance Data Advanced ICU Care, the nation’s leading provider of high-acuity telemedicine services, today unveiled 2018 clinical…Arboretum_JDApril 10, 2019
Fifth EyeHome PageNews Page Fifth Eye Inc. Raises $11.5M Series A Funding Round Led by Arboretum Ventures and Cultivation Capital Fifth Eye uses continuous physiologic waveforms to build clinical early warning systems that enable proactive…Arboretum_JDApril 1, 2019
News PageStrata Oncology Strata Oncology Launches Expanded StrataNGS for Patients with Advanced Cancer Strata OncologyTM, a leading precision oncology company, today announced the launch of version 3.0 of…Arboretum_JDMarch 20, 2019
Home PageNews PageSI-Bone SI-BONE, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results SI-BONE, Inc. (Nasdaq:SIBN), a medical device company that pioneered the minimally invasive surgical treatment of…Arboretum_JDMarch 7, 2019
Home PageNews PageNxThera New Four-Year Data Demonstrate Rezūm™ Water Vapor Therapy Offers Significant Durable Improvement of Benign Prostatic Hyperplasia Symptoms Boston Scientific Corporation (NYSE: BSX) today announced that data from a randomized clinical trial demonstrate…Arboretum_JDJanuary 29, 2019
Cardiac DimensionsNews Page Cardiac Dimensions Appoints Carmelo Mastrandrea as Vice President of Sales Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatment modalities to address…Arboretum_JDJanuary 15, 2019